passionate about transforming data into discoveries
Developing novel medicines require novel insights. We have spent the last decade developing and refining the inBio PlatformTM as an instrument to obtain crucial new insights from the wealth of available data.
The inBio PlatformTM combines multi-omics analysis with network biology-driven AI to help accelerate and improve data-driven R&D. It has proven to facilitate a better understanding of biology, diseases, and patients and more than double the outcome of R&D projects.
We use the inBio Platform to drive our own R&D projects, and we partner with life science companies to help them develop tomorrow’s medicine using the Platform.
each of the inBio PlatformTM elements offer significant benefits and performance gains:
The multi-omics approach has proven to double the outcome of biomarker and target discovery projects, while the network medicine component in an independent head-to-head benchmark performed by GSK was shown to be 40 % better than other platforms in discovering novel biology.
of top20 pharma use the platform
Only when data is put in the right context, can the optimal interpretations be made.
Combining and visualizing data has always been a key focus of Intomics. We have helped many clients shorten their path to important conclusions by ingenious visualizations, and can also help you extract more insight from your data.
what our clients say
inBio is by far the most powerful platform for data-driven network analysis out there
inBio Discover translates a wealth of data into biological insights - in a user-friendly interface
inBio Discover user
try the inBio Platform.
transforming data into discoveries.